Combined laboratory and imaging indicators to construct risk models for predicting immunotherapy efficacy and prognosis in non-small cell lung cancer: An observational study (STROBE compliant).

This study evaluated pretreatment laboratory and imaging parameters to predict the short- and long-term efficacy of immu...

Continue ReadingCombined laboratory and imaging indicators to construct risk models for predicting immunotherapy efficacy and prognosis in non-small cell lung cancer: An observational study (STROBE compliant).

Local consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression.

This retrospective study evaluated the impact of local consolidative therapy (LCT) on survival in 127 metastatic non-sma...

Continue ReadingLocal consolidative therapy extends survival in metastatic NSCLC with oligoresidual disease following first-line immunotherapy, irrespective of PD-L1 expression.